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Summary
The novel Ras effector mNore1, capable of inducing
apoptosis, is a multidomain protein. It comprises a
C1 domain homologous to PKC and an RA domain
similar to the Ras effectors AF-6 and RalGDS. Here,
we determine the affinity of these two domains to the
active forms of Ras and Rap1 using isothermal calori-
metric titration. The interaction of Ras/Rap1-GTP with
the RA domain of mNore1 is weakened significantly by
direct binding of the C1 domain to the RA domain. In
order to analyze this observation in atomic detail, we
solved the C1 solution structure by NMR. By determin-
ing chemical shifts and relaxation rates, we can show
an intramolecular complex of C1-RA. GTP-Ras titration
and binding to RA disrupts this complex and displaces
the C1 domain. Once the C1 domain tumbles freely in
solution, a lipid binding interface becomes accessible.
Furthermore, we provide evidence of phosphatidylino-
sitol 3-phosphate binding of the free C1 domain.
Introduction
Small GTPases of the Ras family are central regulators
of cellular signal transduction processes leading to cell
proliferation, cell differentiation, and apoptosis (Shields
et al., 2000; Feig and Buchsbaum, 2002; Cox and Der,
2003). Ras signaling is mediated by Ras effectors, in-
cluding Raf, the RalGEF family member RalGDS, phos-
phatidylinositol (PI) 3-kinase, AF-6, and the novel Ras
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wald, Germany.effector Nore1. These multidomain proteins contain
a Ras association (RA) domain that tightly binds to ac-
tive Ras/Rap-GTP, but not inactive Ras/Rap-GDP. In
addition, the effectors Raf and RalGDS contain catalytic
and signal transducing domains, whereas the effectors
AF-6 and Nore1 more likely function as adaptors, at-
tracting other proteins (Radziwill et al., 2003).
Nore1 was first discovered in a yeast two-hybrid
screen of a mouse cDNA library by using Ras as the
bait (Vavvas et al., 1998). There are two human splice var-
iants, Nore1A and Nore1B, which have been assigned to
the Ras association family (RASSF). Within the primary
sequence of Nore1, five regions can be assigned: the
N-terminal proline-rich region, able to bind RASSF1A
(Ortiz-Vega et al., 2002), is followed by a cysteine-rich
domain. Next, there is a region of w100 amino acids,
which, by using deletions, was implicated in Ras-inde-
pendent inhibition of tumor cell growth (Aoyama et al.,
2004). Adjacent to this stretch of residues, the RA do-
main can be found. The C terminus putatively forms
a coiled-coil structure. It has been used to immunopre-
cipitate the kinase Mst1, known to be responsible for
promotion of apoptosis (Khokhlatchev et al., 2002).
The cysteine-rich domain shares homology with the
C1 domains of PKC and Raf. C1 domains have been im-
plicated in intramolecular complexes, which mediate
autoinhibition of these kinases (Medkova and Cho, 1999;
Cutler et al., 1998). Additionally, C1 domains can interact
with membrane lipids. Typical C1 domains bind diacyl-
glycerol or phorbol ester, whereas atypical domains
have other specificity. Residues involved in phorbol es-
ter binding of PKCg or PKCd, for example, have been
identified by using NMR spectroscopy (Xu et al., 1997)
and crystallography (Zhang et al., 1995), respectively. A
diacylglycerol binding consensus sequence could be
derived (Hurley and Misra, 2000). There has been contro-
versy about direct binding of the Raf C1 domain to Ras
(Hu et al., 1995; Cutler et al., 1998). A better understand-
ing of the role of the C1 domain may shed light on mech-
anisms of effector activation and/or translocation.
In this study, we resolve the structure of the C1 do-
main of mNore1 by heteronuclear NMR spectroscopy.
Further, we investigate its interaction with the RA do-
main and with Ras by NMR titration, as well as by iso-
thermal titration calorimetry (ITC). We find no direct
binding of C1 to Ras; instead, we can demonstrate an
intramolecular complex of the C1 and RA domains of
Nore1. Titration of Ras disrupts this intramolecular com-
plex, allowing the C1 domain to tumble freely in solution
and to bind other interaction partners. Using a protein-
lipid overlay assay, we further demonstrate phosphati-
dylinositol 3-phosphate and sulfatide binding of the
free C1 domain of Nore1.
Results
Structure Description
We determined the structure of the C1 domain of Nore1
(residues Pro95–Arg166) by using high-resolution,
heteronuclear, multidimensional NMR spectroscopy.
Structure
882Figure 1. The Structure of the C1 Domain of mNore1
(A) Ribbon representation of 30 calculated structures superpositioned onto the average structure.
(B) The same ensemble, but shown as a stick representation.Figure 1 shows the superposition of the 30 energetically
most favorable C1 models. The well defined fold of the
C1 domain (residues Cys118–Cys165) consists of a dis-
torted five-stranded, antiparallel b sheet with a helix on
one side of the sheet. The fold is stabilized by two zinc
clusters, connecting the helix and the sheet (Figure 1).
The five-stranded b sheet comprises a three- and
a two-stranded part. The three-stranded region consists
of strands 1, 4, and 5 (residues Val121–Leu123, Ala143–
Arg145, and Phe151–Cys153, respectively), while the
second part encompasses strands 2 and 3 (residues
Gly130–Cys132 and Arg137–Val139, Figure 2). Strands
2 and 3 as well as 4 and 5 are connected by b turn ele-
ments, which are found on the same side of the b sheet.
The first of these two b turns is stabilized by hydrogen
bonds between the carbonyl oxygen of Cys132 and the
backbone amide groups of Cys135 and Gly136. The sec-
ond b turn is stabilized by the same pattern, where
Cys146 binds to Cys149 and Lys150. Strands 1 and 2
as well as 3 and 4 are connected by long loops which
can be found on the opposite side of the b sheet (Fig-
ure 1). The first of these two loops seems to be flexible,
since it shows large conformational variations (Figure 1).
The helix (Gln156–Ile161, Figure 2) is only weakly defined
Figure 2. Alignment of C1 Domains
The sequence of the C1 domain of mNore1 was aligned by using the
program pileup (Wisconsin Package 9.1, Genetics Computer
Group). By using structural information, the alignment was refined
with the program SPV (Guex and Peitsch, 1997). The secondary
structure of the mNore1 C1 domain, deduced from the NOE and hy-
drogen bonding network, is display above the alignment. The resi-
dues marked in red, yellow, and blue correspond to the RA binding
interface of the mNore1 C1 domain, defined by changes during Ras
titration by using NMR. The green and cyan boxes below the align-
ment mark residues of PKCg that interact tightly with phorbol ester
(green) or change their NMR signals during lipid micelle titration
(cyan) (Xu et al., 1997).by NOEs. The hydrophobic core is formed by amino
acids His118, Phe120, Cys132, Val139, Ala143, Leu144,
Cys146, Cys149, Cys153, and Ile161. Additionally, the
side chains of Lys150 (b, g, and d methylen groups) and
Phe151 contribute to the hydrophobic core. The tetrahe-
dral zinc coordination is conserved among C1 domains
(Mott et al., 1996; Chen et al., 2000). Zn1 connects
b strands 2 and 3 (S-Cys132 and S-Cys135) with the N
terminus of the helix (Nd-His154 and S-Cys157). Adop-
tion of a different rotamer by evolutionary weakly
conserved Cys153 would allow for alternate Zn1 coordi-
nation (mean S-Cys153 Zn1 distance of 6.6 A˚). The sec-
ond zinc ion attaches S-Cys165, located five amino acids
from the C terminus of the helix, to b strands 1, 4, and 5
(Nd-His118, S-Cys146, and S-Cys149 respectively).
Without considering the flexible parts, the ensemble
superpositions well, with a backbone rmsd of 0.41 A˚.
Table 1. Statistics of Structure Calculation
Number of NOE distance constraints
Total 535
Long range (separated by more than 5 A˚) 154
Torsion angle constraints 48
Rms deviation from experimental data
Distance restraints (A˚) 0.0068 6 0.0007
Dihedral restraints (º) 2.4 6 1.2
Rms deviation from ideal geometrya
Bonds (A˚) 0.015 6 0.001
Angles (º) 1.76 6 0.08
Dihedrals (º) 16.2 6 1.4
Rms deviation from the structure
with the lowest energy for residues
118–122 and 131–161b (A˚)
Backbone atoms 0.42
All atoms except hydrogen 1.13
Ramachandran plotc (%)
Most favored regions 73.9
Additionally allowed regions 24.4
Generously allowed regions 1.7
Disallowed regions 0.0
a Calculated with the program CNS (Brunger et al., 1998).
b Calculated with the program molmol (Koradi et al., 1996).
c Calculated with the program procheck (Laskowski et al., 1993).
Ras Disrupts the Intramolecular Complex of Nore1
883Figure 3. Superposition of Three C1 Domains
The C1 domains of mNore1 (blue), Raf kinase
(gray), and PKCg (yellow) were superposi-
tioned (Jung and Lee, 2000). The stereoimage
was calculated by using the programs Yasara
and Povray. The phorbol ester binding site
of PKCg is located at the upper left of the
molecule.For all atoms, excluding hydrogens, an rmsd of 1.13 A˚
was calculated (Table 1). A total of 74% of the f and c
torsion angles are within the most favored region of
the Ramachandran plot, 24% are in the allowed region,
and the rest are in the generously allowed region (Las-
kowski et al., 1993).
The diacylglycerol consensus sequence (Hurley and
Misra, 2000) is not conserved in the C1 domain of
mNore1 (Figure 2). The loop connecting b strands 3 and
4 is three amino acids shorter in mNore1 compared to
PKCg (Figures 2 and 3). The structurally important gly-
cine residue, necessary for diacylglycerol binding (Hur-
ley and Misra, 2000), is missing from this loop. Thus,
we classify the C1 domain of Nore1 as an atypical C1
domain.
Affinity of Ras for mNore1 Fragments
To examine the function of the C1 domain of mNore1 dur-
ing Ras binding, we used isothermal titration calorimetry
(ITC). This method allows us to quantify the interaction
between any partners, if there is a change in enthalpy
upon binding. For example, titration of Ras-GppNHp (a
nonhydrolyzable GTP analog) with the RA domain of
mNore1 sets free a large complex formation enthalpy
(Figure 4). Ras and the RA domain bind each other with
high affinity (Table 2). Using a longer RA construct that
additionally comprises the C1 domain of mNore1 (C1-
RA), decreases the Ras affinity by a factor of two (Fig-
ure 4). The attached C1 domain leads to a reduction of
free interaction energy (0.5 kcal/mol) between Ras and
the RA domain. A similar observation is made with the
closely related small GTPase Rap, which, like Ras, binds
the RA domain of mNore1 with high affinity (Table 2).
Again, use of the longer C1-RA fragment lowers the
Rap affinity, in this case by a factor of 3 (Table 2).
C1-induced structural changes of the RA domain can
explain the decreased affinity. Alternatively, competition
between the C1 domain and Ras for the RA domain can
occur. Supporting the later explanation, we can show di-
rect binding between the separately expressed C1 and
RA domains. The titration was carried out in both
ways: by adding either RA to C1 or vice versa. Within
an error of 20%, we obtained a KD value of 50 mM, corre-
sponding to a free energy difference (DGº) of C1/RA
complex formation of 25.9 kcal/mol. Since bothdomains are contained on one polypeptide chain, the
two domains can be expected to form an intramolecular
complex. Upon addition of Ras, this complex is dis-
solved, which explains the observed reduction of Ras
affinity.
Ras Disrupts the Intramolecular Complex
between C1 and RA Domains
Complex formation or dissociation can be followed
on the atomic level by using NMR titrations. 15N-HSQC
spectra of the C1-RA construct were recorded before,
during, and after addition of Ras-GppNHp (Figure 5). In
a spectrum of the C1-RA construct, resonances belong-
ing to nuclei of the C1 domain display chemical shifts
clearly different from those of the free C1 domain. This
is not only due to the higher molecular weight of the con-
struct. Addition of Ras-GppNHp shifts the HSQC signals
Figure 4. Isothermal Titration Calorimetry
Ras-GppNHp at 500 mM was placed in the syringe of the ITC appa-
ratus and titrated into the cell containing the C1-RA construct of
Nore1 at 50 mM (upper panel). Changes in heating power were inte-
grated and plotted versus the molar ratio of Ras/Nore1. The lower
panel shows such data for Ras/RA (filled squares) and Ras/C1-RA
(open squares). A fit according to a single site binding model yielded
the thermodynamic data given in Table 2.
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titration, 17 signals change their chemical shift, until they
return to values observed in the spectrum of the free C1
domain (Figure 5). Changes of 0.01–0.2 ppm along the
1H and 0.02–1 ppm along the 15N dimensions are mea-
sured. With respect to the NMR timescale, slow- and
fast-exchanging spins can be distinguished. The signals
of the backbone nitrogen groups of Val121, Glu122,
Gly128, Leu134, and His154 display a continuous chem-
ical shift change that is proportional to the amount of Ras
titrated (fast exchange, Figures 2 and 5). Two signals can
be observed for the amide resonances of Gly130,
Gly136, Arg137, Glu138, Lys150, and Phe151 and the
NH2 group of Asn148. The relative intensity of the pairs
Table 2. Thermodynamic Data of Complex Formation between
Fragments of Nore1 and GppNHp Bound Small GTPases Ras
and Rap Obtained from Isothermal Titration Calorimetry
mNore1-RA mNore1-C1-RA
Ras
Kd (mM) 0.21 6 0.02 0.4 6 0.04
n 1.0 6 0.1 0.9 6 0.1
DHº (kcal/mol) 29.3 6 0.3 26.4 6 0.3
DGº (kcal/mol) 29.1 6 0.1 28.7 6 0.1
Rap1B
Kd (mM) 2.8 6 0.5 8.2 6 1
n 0.85 6 0.2 1.1 6 0.2
DHº (kcal/mol) 25.7 6 0.5 21.5 6 0.5
DGº (kcal/mol) 27.6 6 0.1 28.7 6 0.1
mNore1-C1
Kd (mM) 50 6 10 nd
n 0.85 6 0.2 nd
DHº (kcal/mol) 20.8 6 0.3 nd
DGº (kcal/mol) 25.9 6 0.2 ndchanges according to the concentration of Ras added
(slow exchange, Figures 2 and 5). Five resonances be-
longing to Trp131 (backbone and N31), Cys132,
Asp133, and Thr152 were not found in the 15N-HSQC
spectrum of the C1-RA construct, but the signals reap-
peared upon Ras titration (slow exchange, reappearing
signals, Figures 2 and 5). Together, these 16 residues de-
fine an almost continuous C1-RA interaction interface on
the surface of the C1 domain (see below).
Complex Disruption Confirmed by Relaxation
Measurements
The transverse and longitudinal relaxation rate ratio (R2/
R1) depends on the speed of movement, and it is propor-
tional to the molecular weight (Kai et al., 1989). A single
domain has a smaller ratio than the same domain fixed in
a larger complex. If the intramolecular complex of the
two domains is disrupted, the relaxation rate ratio
should drop to values resembling those of single do-
mains. We measured three sets of 15N relaxation rates:
first, for the free, 72 residue C1 domain, a mean R2/R1 ra-
tio of 2.2 was calculated (Figure 6). For the C1-RA con-
struct, spanning 263 amino acids, the mean R2/R1 ratio
increased to 6.5 (Figure 6). This clearly indicates that
the C1 domain of the C1-RA construct is part of a larger
complex. The third set of relaxation rates was deter-
mined for the C1-RA construct titrated with GppNHp
bound Ras. Here, we find values similar to the relaxation
rate ratio of the free C1 domain (Figure 6). This finding
can be highlighted by looking at Arg158, which shows
an R2/R1 ratio of 2.7 in the free C1 domain (Figure 6). In
the C1-RA construct, this ratio is increased to 6.9, but
it drops to 2.8 after Ras titration. We can conclude thatFigure 5. Changes of NMR Signals during
Titration of the C1-RA Construct with Ras
(A–H) Parts of superpositioned HSQC spectra
are shown for signals where changes were
observed. The signals of the free mNore1-C1
domain are shown in red, the resonances of
the RA-C1 fragment are shown in green, and
the signals of the C1-RA fully titrated with
GppNHp bound Ras are colored in blue. (A)
The proposed model of the domain arrange-
ment is shown in the above-mentioned
colors. (B–H) Parts of the superpositioned
HSQC spectra showing the changes. The rel-
evant amino acids are indicated and under-
lined according to the category of change.
(B)–(D) and (F) are twice as magnified as (E),
(G), and (H).
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C1 domain forms an intramolecular complex with the
RA domain, which is disrupted upon titration with Ras.
Ras binds to the RA domain, thereby displacing the C1
domain, which then tumbles freely in solution. If the
RA and C1 domains tumble around each other totally un-
constrained, the above-described dissociation con-
stants can be used to calculate an average distance of
15 nm (Experimental Procedures). Accordingly, primary
sequence analysis (Bateman et al., 2004) separates the
two domains by 100 amino acids.
Lipid Binding of the mNore1 C1 Domain
The data lead to the question of the function of the
displaced C1 domain. The region of mNore1 C1 corre-
sponding to the lipid binding interface of PKCg (Xu
et al., 1997) can be compared to the C1-RA binding inter-
face. Figure 7 indicates that the potential lipid binding in-
terface is not accessible in the C1-RA intramolecular
complex. Residues in the core of the RA binding inter-
face correspond to phorbol ester binding residues.
Trp131, for example, is centered in the RA binding inter-
face. At this position, PKC contains a phenylalanine,
which displays chemical shift change upon phorbolester
binding (Figure 7) (Xu et al. 1997). Tryptophane is often in-
volved in membrane binding (Yau et al., 1998). If the C1
Figure 6. Comparison of Relaxation Data
Relaxation rates were measured for mNore1-C1 (squares), the RA-
C1 construct (triangles), and the Ras-GppNHp-titrated RA-C1 con-
struct (circles). The R2/R1 quotient was plotted versus the corre-
sponding amino acid.domain is displaced and tumbles freely in solution, we
can expect membrane binding. As predicted, the atypi-
cal mNore1 C1 domain does not bind to diacylglycerol
with significant affinity (data not shown). Instead of ex-
amining individual lipids, the lipid specificity can be de-
termined by using a screening approach. In this assay,
different lipids spotted on a solid support can be probed
by using a GST-C1 fusion protein. The C1 domain binds
to the lipid, and the GST part is used for detection. This
assay reveals high specificity of the mNore1 C1 domain
for two kinds of lipids; phosphatidylinositol 3-phosphate
(PI3P) and sulfatides are labeled selectively (Figure 8).
Similar lipids in which phosphate groups are placed at
different positions, or lipids with additional phosphate
groups, are not bound. Thus, we can answer the ques-
tion posed above: after being displaced, the C1 domain
of mNore1 can bind PI3P with high selectivity.
Discussion
We have solved the solution structure of the C1 domain
of mNore1 by using NMR. Structurally, the C1 domain
of mNore1 closely resembles the C1 domains of PKC,
Raf, or diacylglycerol kinase, with rmsds of 2.3, 3.2,
and 2.6 A˚ respectively. In addition, a search with the pro-
gram Dali (Holm and Sander 1993) revealed that the FYVE
domain of Vps27p (3.1 A˚), the LIM domain of CRP1
(3.4 A˚), and the RING domain of TFIIH (2.7 A˚) are related.
The FYVE domain is known to bind PI3P (Misra and Hur-
ley, 1999). We have provided evidence that the C1 do-
main of Nore1 binds this lipid as well. It is known that
FYVE domains dimerize in vivo (Dumas et al., 2001).
Only a dimer, not a monomer of this domain, can be
used as a marker for endosomal vesicles, in which
PI3P is enriched (Gillooly et al., 2000). Dimerization has
also been reported for Nore1 (Ortiz-Vega et al., 2002).
We found that the C1 and the RA domains of Nore1
form an intramolecular complex. Ras binding to RA dis-
rupts this complex and displaces the C1 domain,
thereby presumably exposing the lipid binding interface
of the C1 domain. Interestingly, membrane localization
of the Nore effector Mst1 has been reported to induce
apoptosis in certain cell lines (Khokhlatchev et al.,
2002). We propose that Ras binding in concert with the
liberation of the C1 lipid binding interface is a mecha-
nism for translocation, and hence activation, of the apo-
ptotic kinase Mst1.Figure 7. Comparison of Binding Surfaces
(A) Ras titration changes the HSQC reso-
nances of C1 domain NH protons. Changes
were sorted into categories and used to color
the surface of the C1 domain. Blue indicates
signals, which reappear upon titration. Yellow
marks residues for which two peaks are
found. Red signals shift continuously.
(B) Residues that participate in lipid binding
of PKCg were mapped onto the molecular
surface of mNore1-C1. Green residues inter-
act tightly with phorbol ester; cyan residues
change their NMR signals during lipid micelle
titration (Xu et al., 1997).
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has been reported that Nore per se inhibits its effector
Mst1 (Praskova et al., 2004). Only upon Ras binding
and membrane translocation is this inhibition releaved.
We showed that Ras binding induces a prominent
change in the quarternary structure of Nore1. This
change could be an explanation for the transition from
inhibition to stimulation of Mst1.
Experimental Procedures
Protein Production
The C1 domain (aa 95–166) or the C1-RA construct (aa 95–358) was
expressed in pGEX4T3 in E. coli BL21 DE3 by using 0.1 mM iso-
propyl-b-D-thiogalactoside. The cells were ultrasonicated, and the
lysate was cleared by centrifugation. The glutathione-S-transferase
(GST) fusion proteins were purified by using GSH affinity chromato-
graphy (GSH sepharose). GST was cleaved with Thrombin (10 U/ml
overnight at 4ºC), and the protein of interest was purified by using gel
filtration (sephadex G75). For 15N or 13C labeling, minimal medium
(Gronwald et al., 2001) was supplemented with 0.75 g/l 15N ammo-
nium chloride or 2.5 g/l 13C glucose. For double labeling, 1 and 2.5
g/l were used, respectively. For NMR experiments, the proteins
were dissolved in 20 mM KHPO4 (pH 6.9), 0.5 mM NaN3, 4 mM
DTE, and 5% D2O. Ras and Rap were purified and loaded with
GppNHp as described (Herrmann et al., 1996; Lenzen et al., 1995),
and they were dissolved in the same buffer for NMR titration.
Lipid Assay
Several different lipids spotted on solid support are available com-
mercially (PIP strips and Sphingo strips, Invitrogen). The intact
GST-C1 fusion was bound to these membranes and detected by
mouse anti-GST antibody, followed by labeling with horseradish
peroxidase-conjugated anti-mouse antibody and chemiluminescent
detection (ECL, Amersham).
Isothermal Titration Calorimetry
The interactions between the protein fragments and the Ras pro-
teins were quantified by isothermal titration calorimetry (MCS,
MicroCal). All proteins were dissolved in 50 mM Tris buffer (pH 7.4) in-
cluding 5 mM MgCl2, which is important for tight nucleotide binding.
The syringe was filled with the protein solution containing the small
GTPase at 500 mM, while the Nore fragment at 50 mM was placed into
Figure 8. Lipid Binding Specificity of the mNore1-C1 Domain
A total of 26 different lipids on a nitrocellulose membrane were
probed with recombinant GST-mNore1-C1 (GST-95-166), were sub-
sequently labeled with anti-GST-antibody and HRP-coupled anti-
mouse antibody, and were followed by ECL detection.the cell of the ITC apparatus. The low-affinity interaction between
the C1 and RA fragments of Nore was measured by using C1 at
100 mM in the cell and 1 mM RA in the syringe, as well as by the in-
verse setup. The titration experiments were carried out in duplicate
at 25ºC by stepwise injection of 8 ml at time intervals of 4 min each. In
blank experiments, the respective protein was injected from the sy-
ringe into the buffer solution, yielding small background heats that
were subtracted from the titration experiments prior to curve fitting.
NMR Spectroscopy
NMR samples containing 2 mM protein were prepared in the above-
described buffer. NMR spectra were recorded on a Varian Inova 600
MHz spectrometer at 300 K, by using States for quadrature detec-
tion. The resonance assignments were obtained by standard homo-
nuclear and heteronuclear correlation experiments such as DQF-
COSY, TOCSY, HNCACB, HCCONH, CCONH, and HCCH-COSY.
The spectra were processed with XWIN-NMR (Bruker, Karlsruhe)
by using the cosines square function as the windows function, and
zero filling was applied in both dimensions. Analysis was done
with Aurelia and Auremol (Bruker, Karlsruhe). All backbone reso-
nances, except for Gly127 and Ser155, were assigned (BMRB ac-
cession number 6059).
For the titration experiment, subsequent amounts of a solution
containing 68 mg/ml Ras-GppNHp were added to a solution con-
taining 13 mg/ml C1-RA.
Structure Calculation
The structure calculation was based on 535 distance and 48 dihedral
angle restraints by using a three-step procedure implemented in the
molecular simulation program YASARA ([Krieger, 2003], detailed
protocols are available from www.yasara.org/sd). In each step, the
restraints were enforced with the X-PLOR soft-square potential
(Brunger, 1992) with parameters SqConstant = 1, SqOffset = 0,
SqExponent = 2, rSwitch = 1, SoExponent = 1, and Asymptote = 2.
To fold the initially stretched-out peptide chain to a globular pro-
tein, backbone and side chain dihedral angles were changed ran-
domly, and a Monte Carlo criterion based on the restraint violation
energy was used to accept or reject a move. No additional force field
term was applied.
Next, structures were subjected to 40 cycles of heating (500 K) and
cooling (0 K) by using the NOVA force field (Krieger et al., 2002) with
a 10 A˚ cutoff. At this point, the two zinc ions were added to the sys-
tem. In the first three cycles, intermolecular forces were partly re-
moved to let parts of the peptide chain pass through each other
and resolve incorrect topologies.
In the final step, the protein was embedded in a water box, 10 A˚
larger than the protein along each axis. Then, a molecular dynamics
simulation was run at 300 K with the YASARA force field, which is an
extension of the YAMBER2 force field (Krieger et al., 2004; Kuszew-
ski and Clore, 2000), with knowledge-based torsion potentials for
more accurate high-resolution refinement. Simulations lasted 2 ps;
an 8 A˚ cutoff for Van der Waals forces and the Particle Mesh Ewald
algorithm (Essman et al., 1995) were used for electrostatic forces. To
make sure that the resulting structures completely matched the ex-
perimental data, the entire solute/solvent system was then energy
minimized (by multiplying atom velocities with 0.9 every 10 simula-
tion steps) while checking for NMR restraint violations. If any were
found, the restraining forces were increased steadily until the viola-
tion energy was marginal (<1 kcal/mol). A total of 30 structures with
the lowest energy were chosen for the ensemble representing the
structure and were analyzed (Table 1).
Average Distance between C1 and RA Domains
Using the ITC dissociation constants (Table 2), the concentration of
the free C1 domain, as it tumbles around the RA domain, can be cal-
culated. To distinguish covalent, noncovalent, and both interactions
from each other, the symbols (_), (#), and (#), respectively, are used in
the following equations.
Ras binding takes place as a two-step process. First, there is an
equilibrium of the C1-RA construct (Equation 1). Ras binds to the
free RA (Equation 2), thereby removing the product of Equation 1:
C1#RA#C1 RA; (1)
C1RA+ Ras#C1RA#Ras; (2)
Ras Disrupts the Intramolecular Complex of Nore1
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The overall reaction (Equation 3) has been measured directly by
NMR, as well as by ITC. A dissociation constant of K3D = 0.4 mmol/
l has been determined. The main assumption of the model is that
the covalent linker does not influence the equilibrium constants. In
this case, the constant of Equation 2 can be measured by titrating
RA with RAS (Equation 4, K4D = K2D = 0.2 mmol/l):
RA+RAS#RA#Ras: (4)
The binding event of the intramolecular reaction (Equation 1) can
be described by the intermolecular Equation 5, in which a dissocia-
tion constant of K5D = 50 mmol/l has been determined (Table 2):
C1 +RA#C1#RA: (5)
If we define the concentration of RA as being equal to that of
C1_RA, we can determine at which concentration of C1 equal con-
centrations of complexes are found (i.e., how much C1 is needed
such that [C1#RA] = [C1#RA]):
K1D = ½C1 # RA=½C1RA
K5D = ½C1 * ½RA=½C1#RA
0K1D = ½C1eff=K5D: (6)
The equilibrium constant of Equation 1 can be calculated from the
overall Equation 3, in which two steps are added. We can calculate
[C1]eff:
K1D * K2D = K3D0K1D = K3D=K2D
= K3D=K4D
0½C1eff = ðK3D * K5DÞ=K4D = 100 mmol=l: (7)
If we need 100 mmol/l of the C1 domain to achieve the same con-
centration of complex, we can assume that this is the concentration
‘‘sensed’’ by the RA domain in the C1_RA construct.
Hence, we can calculate the volume of the sphere in which the C1
domain tumbles around the RA domain. The radius of this ball cor-
responds to the average distance between the C1 and RA domains
in solution:
r =
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
3 * 102 3
4 *p *NA * ½C1eff
3
s
z16 nm (8)
The same arguments are valid for the binding of the small GTPase
Rap1, in which the dissociation constants have also been deter-
mined (Table 2). Thus, we can calculate an effective C1 concentra-
tion of 150 mM. Accordingly, an average distance of 15 nm between
the C1 domain and the RA domain can be estimated.
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